论文部分内容阅读
目的观察依达拉奉与尼莫地平联合应用于高血压性脑出血的治疗效果。方法将78例高血压性脑出血患者随机分为观察组和对照组各39例。对照组予以常规综合治疗,观察组在对照组的基础上加用依达拉奉及尼莫地平治疗,对比2组的疗效。结果观察组总有效率为89.74%显著高于对照组的71.79%(P<0.05);治疗后观察组的脑水肿体积、血肿体积及血浆ET-1水平显著低于治疗前及对照组(P<0.05);治疗后1周及4周,观察组的NIHSS评分显著低于治疗前及对照组(P<0.05)。结论依达拉奉与尼莫地平联合应用于高血压性脑出血能够显著改善临床症状及神经功能,减轻脑水肿及脑血肿,提高疗效,值得推广应用。
Objective To observe the therapeutic effect of edaravone combined with nimodipine on hypertensive intracerebral hemorrhage. Methods 78 patients with hypertensive cerebral hemorrhage were randomly divided into observation group and control group, 39 cases each. The control group was given conventional comprehensive treatment. The observation group was treated with edaravone and nimodipine on the basis of the control group, and the curative effect was compared between the two groups. Results The total effective rate of the observation group was 89.74%, which was significantly higher than that of the control group (71.79%, P <0.05). The volume of cerebral edema, the volume of hematoma and the level of ET-1 in the observation group were significantly lower than those in the control group <0.05). NIHSS scores in observation group were significantly lower than those before treatment and control group at 1 week and 4 weeks after treatment (P <0.05). Conclusion The combination of edaravone and nimodipine for hypertensive intracerebral hemorrhage can significantly improve clinical symptoms and neurological function, reduce cerebral edema and cerebral hematoma, and improve the curative effect, which is worth popularizing and applying.